Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

Fell in the pool. Gotta wait for it to dry.

But seriously "due to a delay experienced by the Registrant in preparing its financial statements and related disclosure to account for recent changes in the business, and to a lesser extent as a result of the recent change in the Registrant’s independent public accounting firm."
Based on the following the delay looks more like it is due to the Company not being prepared to provide "related disclosure to account for recent changes in the business" than to any accounting issues.
"The Registrant anticipates reporting net loss for the three months ended September 30, 2023 of $0.9 million, as compared to $1.4 million for the three months ended September 30, 2022, largely as a result of decreased research and development expenses (approximately $0.3 million for the three months ended September 30, 2023 compared to $0.9 million for the three months ended September 30, 2022) and general and administrative expenses (approximately $0.1 million for the three months ended September 30, 2023 compared to $0.3 million for the three months ended September 30, 2022), partially offset by an increase in professional fees (approximately $0.3 million for the three months ended September 30, 2023 compared to $0.1 million for the three months ended September 30, 2022)."